-
Mashup Score: 0Embecta discontinues insulin patch pump development - 1 month(s) ago
CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the company “did not intend to do a full market launch of this product.”
Source: www.medtechdive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 21How to Use an Insulin Pump to Bolus for Pizza - 3 month(s) ago
Think insulin pumps can’t handle pizza? Discover how an insulin pump can manage your blood sugar with precise, extended bolus delivery for pizza.
Source: beyondtype1.orgCategories: General Medicine News, PayerTweet-
While most can agree that we love pizza, bolusing for a slice (or two) comes with a unique set of challenges. We partnered with @BeyondType1 to share this guide to help simplify your next pizza night. 🍕 Read here: https://t.co/A0DXovBIea Prescription required for #InsulinPump.… https://t.co/007gqgDKWX https://t.co/Js4R8onLPc
-
-
Mashup Score: 0Medtronic warns on previous software MiniMed 780G in Germany - 1 year(s) ago
Medtronic (NYSE:MDT) issued an urgent field safety notice in Germany to warn of a potential issue with its MiniMed 780G system.
Source: www.drugdeliverybusiness.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@Medtronic warns on previous software #MiniMed780G in #Germany | #diabetes #insulinpump #artificialpancreas https://t.co/nRsstjFan8
-
-
Mashup Score: 0Insulin pump-makers grapple with questions about GLP-1s - 1 year(s) ago
The new class of weight loss drugs has caused a stock selloff, but is unlikely to “meaningfully change the long-term outlook for diabetes,” analysts wrote.
Source: www.medtechdive.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
#Insulinpump-makers grapple with questions about #GLP1 | #weightloss #diabetes https://t.co/efxsEHvBoJ
-
-
Mashup Score: 0Analysts: GLP-1s should have minor impact on insulin pump market - 1 year(s) ago
Analysts are playing down the potentially negative impact of GLP-1 receptor agonists on the diabetes technology industry.
Source: www.drugdeliverybusiness.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Analysts: #GLP1 drugs should have minor impact on #insulinpump market — but will boost #CGM | #diabetes #weightloss https://t.co/MrKv8ljAta
-
-
Mashup Score: 0
The device, with a much smaller form than Tandem’s past pumps, could drive more people to switch from insulin injections, an analyst with Craig-Hallum said.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@Tandemdiabetes Mobi #insulinpump could reaccelerate growth next year: analyst | #diabetes https://t.co/FfksT6ulFT
-
-
Mashup Score: 0
Tandem Diabetes Care (Nasdaq:TNDM) announced today that the FDA cleared its Tandem Mobi automated insulin delivery (AID) system.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet-
#FDA clears @TandemDiabetes #Diabetes Mobi durable automated #insulinpump https://t.co/hbZoTS7luj
-
-
Mashup Score: 0
Medtronic has begun processing orders and will start shipping devices over the next few weeks.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@MDT_Diabetes #Medtronic secures #Medicare coverage for MiniMed 780G #insulinpump | #diabetes https://t.co/GlEiAnlCVF
-
-
Mashup Score: 0Medtronic agrees to buy Korean insulin patch pump maker for $738m to boost diabetes business - 2 year(s) ago
The tubeless, disposable insulin patch made by EOFlow will be integrated into Medtronic’s MiniMed 780G system.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@Medtronic @MDT_Diabetes agrees to buy #Korea insulin patch pump maker EOFlow for $738m to boost #diabetes business | #insulinpump #MnA https://t.co/bsRyi3V6y4
-
-
Mashup Score: 1
The FDA announced today that it cleared the Beta Bionics iLet ACE automated insulin pump and iLet dosing decision software.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet-
#FDA clears automated #insulinpump from @BetaBionics for type 1 #diabetes https://t.co/RcO57xI0mJ
-
.@Embecta discontinues insulin patch pump development as part of a restructuring intended to reduce costs | #insulinpump https://t.co/rZIENlsifb